Cost-effectiveness of Ombitasvir/Paritaprevir/Ritonavir, Dasabuvir+Ribavirin for US Post-Liver Transplant Recurrent Genotype 1 HCV.
about
Effectiveness of Ledipasvir/Sofosbuvir with/without Ribavarin in Liver Transplant Recipients with Hepatitis C.Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection.Cost-Effectiveness of Treatments for Genotype 1 Hepatitis C Virus Infection in non-VA and VA Populations.Elimination of Hepatitis C in Liver Transplant Recipients
P2860
Cost-effectiveness of Ombitasvir/Paritaprevir/Ritonavir, Dasabuvir+Ribavirin for US Post-Liver Transplant Recurrent Genotype 1 HCV.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cost-effectiveness of Ombitasv ...... lant Recurrent Genotype 1 HCV.
@en
type
label
Cost-effectiveness of Ombitasv ...... lant Recurrent Genotype 1 HCV.
@en
prefLabel
Cost-effectiveness of Ombitasv ...... lant Recurrent Genotype 1 HCV.
@en
P2093
P2860
P356
P1433
P1476
Cost-effectiveness of Ombitasv ...... lant Recurrent Genotype 1 HCV.
@en
P2093
Alice Wang
Caroline Huber
Sammy Saab
Timothy Juday
Yuri S Gonzalez
P2860
P304
P356
10.1111/LIV.13033
P577
2015-11-26T00:00:00Z